Neri, B <br/><br/>
Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer.  [electronic resource] 

 -  The Journal of urology  Sep 2002 
 - 956-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-5347 
<br/><br/><label>Standard No.: </label>10.1016/S0022-5347(05)64550-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Deoxycytidine--administration & dosage<br/>Female<br/>Humans<br/>Immunotherapy<br/>Infusions, Intravenous<br/>Injections, Intramuscular<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--pathology<br/>Male<br/>Middle Aged<br/>Gemcitabine